Ingredient | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Hydroquinone |
C
|
|
||||||
Ascorbic Acid |
C
|
|
||||||
Cysteamine |
C
|
|
||||||
Azelaic Acid |
C
|
|
||||||
Niacinamide + Tranexamic Acid |
C
|
|
Product | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Esoterica |
C
|
|
||||||
Aestura Regederm RX White Project |
C
|
|
||||||
Purpose Daily Use UV Moisturiser + Tretinoin |
C
|
|
||||||
Renova |
C
|
|
||||||
RoC Retinol Correxion Deep Wrinkle Night Cream |
C
|
|
Skincare treatments can penetrate more deeply into the skin to provide faster, more dramatic and longer-lasting results than topical products, but they are also much more expensive.
Review all of the scientific evidence before spending thousands of dollars on treatments that won't work, or that make your skin worse due to the side effects.
Log in to register your interest in knowing when information on skincare treatments becomes available on Wisderm.com, and get a 20% discount on launch!
Intervention | Hydroquinone |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Randomised Controlled |
Trial Duration | 28 days |
Participants | 44 |
Intervention | Hydroquinone |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 80 |
Intervention | Hydroquinone |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 155 |
Intervention | Hydroquinone |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 112 days |
Participants | 16 |
Intervention | Hydroquinone |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 329 |
Intervention | Hydroquinone |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Randomised Controlled |
Trial Duration | 56 days |
Participants | 30 |
Intervention | Hydroquinone |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 120 days |
Participants | 40 |
Intervention | Ascorbic Acid |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 20 |
Intervention | Cysteamine |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 120 days |
Participants | 40 |
Intervention | Cysteamine |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Participants | 40 |
Intervention | Azelaic Acid |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 155 |
Intervention | Azelaic Acid |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 329 |
Intervention | Azelaic Acid |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Randomised Controlled |
Trial Duration | 56 days |
Participants | 30 |
Intervention | Azelaic Acid |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 112 days |
Participants | 20 |
Intervention | Niacinamide |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 70 days |
Participants | 232 |
Intervention | Niacinamide |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 56 days |
Participants | 138 |
Intervention | Niacinamide |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 52 |
Intervention | Niacinamide |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 294 days |
Participants | 79 |
Intervention | Retinol |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 56 days |
Participants | 64 |
Intervention | Retinol |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 182 days |
Participants | 106 |
Intervention | Tretinoin |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 299 |
Intervention | Tretinoin |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 112 days |
Participants | 40 |
Intervention | Tretinoin |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 90 days |
Participants | 171 |
Intervention | Thiamidol |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Participants | 37 |
Intervention | Thiamidol |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 80 |
Intervention | Adapalene |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 90 days |
Participants | 171 |
Intervention | Kinetin |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 84 days |
Participants | 18 |
Intervention | Retin-A |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 112 days |
Participants | 40 |
Intervention | Retin-A |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 90 days |
Participants | 171 |
Intervention | Imedeen |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 100 |
Intervention | Imedeen |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Randomised Uncontrolled |
Trial Duration | 336 days |
Participants | 144 |
Intervention | Imedeen |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Participants | 30 |
Intervention | Imedeen |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 90 days |
Participants | 40 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 120 days |
Participants | 50 |
Intervention | Kinerase |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 84 days |
Participants | 18 |
Intervention | Isdinceutics Melatonik |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Controlled |
Trial Duration | 168 days |
Participants | 24 |
Intervention | Eucerin Anti-Pigment Dual Serum + Eucerin Anti-Pigment Day SPF30 + Eucerin Anti-Pigment Night |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 84 days |
Participants | 117 |